EE350 Cost-Effectiveness of Pembrolizumab for Previously treated MSI-H/dMMR Solid Tumors in Canada
Abstract
Authors
François-Xavier Houde Cédric Joyal Daniel Ladino Aris Skandamis Matthew Madin-Warburton Kate Young Grant McCarthy